Bioprocessing

Raw materials can be a major source of variability, affecting development and manufacturing. This conference provides strategies for developing a comprehensive raw material variability testing, characterization and control plan.

New technologies and risk mitigation strategies to detect, prevent and remediate viral contaminations in raw materials, cell culture processes and facilities throughout the entire supply chain.

IBC's Process & Product Validation conference provides insights into the interpretation and implementation of FDA's Process Validation Guidance and QbD approaches, while examining the roles and impact of knowledge management and quality risk management on continuous verification.

IBC's Outsourcing Manufacturing of Biopharmaceuticals conference provides you insights into developing your risk-mitigation strategies and operational excellence that oversees supply chain security and raw material reliability, thereby delivering a successful agent-sponsor relationship and ensuring consistent high quality products from your CMO partners.

IBC's Technology Transfer for Biopharmaceuticals gives you an inside look at trouble-shooting transfer challenges while developing strategies to minimize risk, enhance productivity, and ensure efficient and smooth technology transfers.

The flexibility of these 9 conferences taking place during IBC's Biopharmaceutical Development & Production Week, allows you to pick and choose the sessions that are the best fit for you so you can get the most out of your time at the event.

The Antibody Development & Production conference offers you the highest quality and most in-depth coverage of the latest technical and scientific advances in bioprocessing to help companies (of all sizes) improve the speed, quality and cost of developing and producing antibodies.

The Recombinant Protein & Complex Biologic Development & Production conference covers the entire spectrum of topics related to improving the efficiency of developing and producing next generation and novel molecules.

This conference offers you the unique opportunity to hear how your peers are successfully developing and integrating novel analytical approaches and technologies to optimize quality at every stage of process and product development.

Attend this conference to hear biobetter development strategies and biosimilar comparability studies from Centocor, Teva, Xencor, Amunix, Ambrx, Aegis, Antares, Macrogenics, Bayer, Biogen Idec, AnaptysBio, PharmaEssentia, Eureka, Amgen, Johnson & Johnson, Simcere, and more!